Karyopharm Therapeutics Inc. (KPTI)
NASDAQ: KPTI · Real-Time Price · USD
9.14
+0.45 (5.18%)
Jun 10, 2026, 9:44 AM EDT - Market open
Karyopharm Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Leerink Partners No rating | Leerink Partners | Hold Reiterates $5 → $7 | Hold | Reiterates | $5 → $7 | -23.41% | May 15, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $16 | Buy | Maintains | $16 | +75.05% | May 15, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $8 → $13 | Buy | Reiterates | $8 → $13 | +42.23% | May 7, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $8 → $16 | Buy | Reiterates | $8 → $16 | +75.05% | Apr 27, 2026 |
| Robert W. Baird | Robert W. Baird | Buy Maintains $21 → $15 | Buy | Maintains | $21 → $15 | +64.11% | Mar 25, 2026 |
| Rodman & Renshaw | Rodman & Renshaw | Buy Initiates $28 | Buy | Initiates | $28 | +206.35% | Mar 9, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Mar 7, 2026 |